N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide

Catalog No. :
ACOFDU709
CAS No. :
90357-51-0
Molecular Formula :
C12H9F3N2O2
Molecular Weight :
270.21

IUPAC Name:N-(4-cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide

N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$83.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide
IUPAC NameN-(4-cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide
MDL No.MFCD08460201
Molecular FormulaC12H9F3N2O2
Molecular Weight270.21
SMILESO=C(C1(C)OC1)NC2=CC=C(C#N)C(C(F)(F)F)=C2
InChI KeyUQUQTWDUTIAAAY-UHFFFAOYSA-N
SynonymSCHEMBL202481 | SY033473 | CS-0153887 | N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyl-oxirane-2-carboxamide | N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide | AKOS015900542 | Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxirane carbox
CAS No.90357-51-0
PubChem CID10149314

Safety Data

Pictogram
Harmful or irritantHealth hazard
Signal Word
Achtung
Hazard Statement(s)
H332-H315-H319-H341
Precautionary Statement(s)
P201-P261-P264-P280-P302+P352+P312-P304+P340+P312

Synthetic Route by SureRoute

1. ACOFDU709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHSEC653 route compound structure diagram
    ACHSEC65390357-53-2
  2. Then
  3. ACOFDU709 route product structure diagram
    ACOFDU70990357-51-0 In Stock
Inquiry

2. ACOFDU709 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHSEC653 route compound structure diagram
    ACHSEC65390357-53-2
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOFDU709 route product structure diagram
    ACOFDU70990357-51-0 In Stock
Inquiry

Comments (0)